TuHURA Biosciences, Inc.

HURA · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
12/31/2024
9/30/2024
Operating Activities
Net Income-$16,188-$5,996-$2,161
Dep. & Amort.$27$18$29
Deferred Tax$0$0$0
Stock-Based Comp.$2,832$0$101
Change in WC$2,342$2,128$152
Other Non-Cash$0$1,251-$10
Operating Cash Flow-$10,987-$2,600-$1,889
Investing Activities
PP&E Inv.-$48-$21$0
Net Acquisitions-$1,259$0$0
Inv. Purchases$0-$802$0
Inv. Sales/Matur.$0$0$0
Other Inv. Act.$0$0$0
Investing Cash Flow-$1,308-$824$0
Financing Activities
Debt Repay.$0-$5$27,456
Stock Issued$5,915$916$0
Stock Repurch.-$500$0$0
Dividends Paid-$4$0$0
Other Fin. Act.-$886-$4,427$0
Financing Cash Flow$8,150-$3,516$0
Forex Effect$0$0$0
Net Chg. in Cash-$4,144$0-$1,889
Supplemental Information
Beg. Cash$12,657$19,596$4,909
End Cash$8,513$12,657$3,020
Free Cash Flow-$11,035-$2,621-$1,889
TuHURA Biosciences, Inc. (HURA) Financial Statements & Key Stats | AlphaPilot